Outcome of treatment of chronic myeloid leukemia with second-generation tyrosine kinase inhibitors after imatinib failure

AM Cornelison, H Kantarjian, J Cortes… - … Lymphoma Myeloma and …, 2011 - Elsevier
Although imatinib revolutionized the management of chronic myeloid leukemia (CML),
recent data indicate a transformation in the treatment approach likely in the near future. For …

[HTML][HTML] Outcome of Treatment of CML with 2nd Generation Tyrosine Kinase Inhibitors After Imatinib Failure

AM Cornelison, H Kantarjian, J Cortes… - … lymphoma, myeloma & …, 2011 - ncbi.nlm.nih.gov
Although imatinib revolutionized the management of chronic myeloid leukemia (CML),
recent data indicate a transformation in the treatment approach likely in the near future. For …

Outcome of treatment of chronic myeloid leukemia with second-generation tyrosine kinase inhibitors after imatinib failure.

AM Cornelison, H Kantarjian, J Cortes… - … Lymphoma, Myeloma & …, 2011 - europepmc.org
Although imatinib revolutionized the management of chronic myeloid leukemia (CML),
recent data indicate a transformation in the treatment approach likely in the near future. For …

Outcome of treatment of chronic myeloid leukemia with second-generation tyrosine kinase inhibitors after imatinib failure

AM Cornelison, H Kantarjian… - Clinical …, 2011 - mdanderson.elsevierpure.com
Although imatinib revolutionized the management of chronic myeloid leukemia (CML),
recent data indicate a transformation in the treatment approach likely in the near future. For …

Outcome of Treatment of Chronic Myeloid Leukemia With Second-Generation Tyrosine Kinase Inhibitors After Imatinib Failure

AM Cornelison, H Kantarjian, J Cortes… - … Lymphoma Myeloma and …, 2011 - infona.pl
Although imatinib revolutionized the management of chronic myeloid leukemia (CML),
recent data indicate a transformation in the treatment approach likely in the near future. For …

Outcome of Treatment of Chronic Myeloid Leukemia With Second-Generation Tyrosine Kinase Inhibitors After Imatinib Failure

AM Cornelison, H Kantarjian… - Clinical …, 2011 - clinical-lymphoma-myeloma …
Although imatinib revolutionized the management of chronic myeloid leukemia (CML),
recent data indicate a transformation in the treatment approach likely in the near future. For …

Outcome of treatment of chronic myeloid leukemia with second-generation tyrosine kinase inhibitors after imatinib failure

AM Cornelison, H Kantarjian… - Clinical Lymphoma …, 2011 - augusta.elsevierpure.com
Although imatinib revolutionized the management of chronic myeloid leukemia (CML),
recent data indicate a transformation in the treatment approach likely in the near future. For …

Outcome of treatment of chronic myeloid leukemia with second-generation tyrosine kinase inhibitors after imatinib failure

AM Cornelison, H Kantarjian… - Clinical lymphoma …, 2011 - pubmed.ncbi.nlm.nih.gov
Although imatinib revolutionized the management of chronic myeloid leukemia (CML),
recent data indicate a transformation in the treatment approach likely in the near future. For …

Outcome of treatment of chronic myeloid leukemia with second-generation tyrosine kinase inhibitors after imatinib failure.

AM Cornelison, H Kantarjian, J Cortes… - … Lymphoma, Myeloma & …, 2011 - europepmc.org
Although imatinib revolutionized the management of chronic myeloid leukemia (CML),
recent data indicate a transformation in the treatment approach likely in the near future. For …